1 Min Read
Jan 2 (Reuters) - Natco Pharma Ltd
* Natco Pharma Ltd says Natco launches Velpanat in Nepal
* Natco Pharma Ltd says Epclusa is used for the treatment of patients with HCV Genotype 2 and 3 Source text - (bit.ly/2hIPKwp) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.